CELESTICA INC (CLS.CA) Stock Fundamental Analysis

Canada • Toronto Stock Exchange • TSX:CLS • CA15101Q2071

389.83 CAD
+7.2 (+1.88%)
Last: Feb 2, 2026, 07:00 PM
Fundamental Rating

6

Taking everything into account, CLS scores 6 out of 10 in our fundamental rating. CLS was compared to 14 industry peers in the Electronic Equipment, Instruments & Components industry. While CLS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CLS has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year CLS was profitable.
  • In the past year CLS had a positive cash flow from operations.
  • Of the past 5 years CLS 4 years were profitable.
  • Of the past 5 years CLS 4 years had a positive operating cash flow.
CLS.CA Yearly Net Income VS EBIT VS OCF VS FCFCLS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

  • CLS's Return On Assets of 10.85% is amongst the best of the industry. CLS outperforms 100.00% of its industry peers.
  • CLS's Return On Equity of 35.33% is amongst the best of the industry. CLS outperforms 100.00% of its industry peers.
  • The Return On Invested Capital of CLS (21.33%) is better than 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CLS is in line with the industry average of 9.87%.
  • The 3 year average ROIC (11.43%) for CLS is below the current ROIC(21.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.85%
ROE 35.33%
ROIC 21.33%
ROA(3y)4.63%
ROA(5y)3.55%
ROE(3y)15.02%
ROE(5y)11.3%
ROIC(3y)11.43%
ROIC(5y)8.93%
CLS.CA Yearly ROA, ROE, ROICCLS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • With a decent Profit Margin value of 6.35%, CLS is doing good in the industry, outperforming 78.57% of the companies in the same industry.
  • CLS's Profit Margin has improved in the last couple of years.
  • CLS's Operating Margin of 7.33% is fine compared to the rest of the industry. CLS outperforms 78.57% of its industry peers.
  • CLS's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 12.04%, CLS is doing worse than 78.57% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CLS has grown nicely.
Industry RankSector Rank
OM 7.33%
PM (TTM) 6.35%
GM 12.04%
OM growth 3Y24.27%
OM growth 5Y29.03%
PM growth 3Y34%
PM growth 5Y30.13%
GM growth 3Y8.03%
GM growth 5Y10.39%
CLS.CA Yearly Profit, Operating, Gross MarginsCLS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

6

2. Health

2.1 Basic Checks

  • CLS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • There is no outstanding debt for CLS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLS.CA Yearly Shares OutstandingCLS.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CLS.CA Yearly Total Debt VS Total AssetsCLS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • An Altman-Z score of 6.76 indicates that CLS is not in any danger for bankruptcy at the moment.
  • CLS has a better Altman-Z score (6.76) than 64.29% of its industry peers.
  • The Debt to FCF ratio of CLS is 1.97, which is an excellent value as it means it would take CLS, only 1.97 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.97, CLS belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
  • CLS has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of CLS (0.37) is worse than 64.29% of its industry peers.
  • Although CLS does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 1.97
Altman-Z 6.76
ROIC/WACC1.44
WACC14.84%
CLS.CA Yearly LT Debt VS Equity VS FCFCLS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • CLS has a Current Ratio of 1.47. This is a normal value and indicates that CLS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CLS (1.47) is comparable to the rest of the industry.
  • A Quick Ratio of 0.88 indicates that CLS may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.88, CLS is in line with its industry, outperforming 42.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 0.88
CLS.CA Yearly Current Assets VS Current LiabilitesCLS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

6

3. Growth

3.1 Past

  • CLS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.59%, which is quite impressive.
  • The Earnings Per Share has been growing by 43.67% on average over the past years. This is a very strong growth
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%43.57%

3.2 Future

  • Based on estimates for the next years, CLS will show a very strong growth in Earnings Per Share. The EPS will grow by 33.06% on average per year.
  • The Revenue is expected to grow by 28.15% on average over the next years. This is a very strong growth
EPS Next Y38.59%
EPS Next 2Y37.93%
EPS Next 3Y33.06%
EPS Next 5YN/A
Revenue Next Year32.94%
Revenue Next 2Y32.93%
Revenue Next 3Y28.15%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CLS.CA Yearly Revenue VS EstimatesCLS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CLS.CA Yearly EPS VS EstimatesCLS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 47.14, which means the current valuation is very expensive for CLS.
  • Compared to the rest of the industry, the Price/Earnings ratio of CLS indicates a rather cheap valuation: CLS is cheaper than 85.71% of the companies listed in the same industry.
  • CLS is valuated expensively when we compare the Price/Earnings ratio to 28.41, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 34.01 indicates a quite expensive valuation of CLS.
  • Based on the Price/Forward Earnings ratio, CLS is valued cheaper than 92.86% of the companies in the same industry.
  • CLS's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 25.64.
Industry RankSector Rank
PE 47.14
Fwd PE 34.01
CLS.CA Price Earnings VS Forward Price EarningsCLS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLS indicates a somewhat cheap valuation: CLS is cheaper than 78.57% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, CLS is valued a bit cheaper than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 82.53
EV/EBITDA 33.7
CLS.CA Per share dataCLS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • CLS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of CLS may justify a higher PE ratio.
  • A more expensive valuation may be justified as CLS's earnings are expected to grow with 33.06% in the coming years.
PEG (NY)1.22
PEG (5Y)1.08
EPS Next 2Y37.93%
EPS Next 3Y33.06%

0

5. Dividend

5.1 Amount

  • CLS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CELESTICA INC

TSX:CLS (2/2/2026, 7:00:00 PM)

389.83

+7.2 (+1.88%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)01-28
Earnings (Next)04-22
Inst Owners73.66%
Inst Owner ChangeN/A
Ins Owners0.59%
Ins Owner ChangeN/A
Market Cap44.85B
Revenue(TTM)N/A
Net Income(TTM)716.70M
Analysts81.11
Price Target347.67 (-10.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.15%
Min EPS beat(2)6.6%
Max EPS beat(2)11.71%
EPS beat(4)4
Avg EPS beat(4)6.73%
Min EPS beat(4)1.95%
Max EPS beat(4)11.71%
EPS beat(8)8
Avg EPS beat(8)9.68%
EPS beat(12)12
Avg EPS beat(12)8.66%
EPS beat(16)16
Avg EPS beat(16)9.16%
Revenue beat(2)2
Avg Revenue beat(2)6.2%
Min Revenue beat(2)5%
Max Revenue beat(2)7.4%
Revenue beat(4)3
Avg Revenue beat(4)3.54%
Min Revenue beat(4)-0.75%
Max Revenue beat(4)7.4%
Revenue beat(8)7
Avg Revenue beat(8)3.49%
Revenue beat(12)11
Avg Revenue beat(12)3.14%
Revenue beat(16)14
Avg Revenue beat(16)3.37%
PT rev (1m)0%
PT rev (3m)29.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.32%
EPS NY rev (1m)0%
EPS NY rev (3m)8.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)13.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.83%
Valuation
Industry RankSector Rank
PE 47.14
Fwd PE 34.01
P/S 2.91
P/FCF 82.53
P/OCF 59.5
P/B 16.2
P/tB 23.27
EV/EBITDA 33.7
EPS(TTM)8.27
EY2.12%
EPS(NY)11.46
Fwd EY2.94%
FCF(TTM)4.72
FCFY1.21%
OCF(TTM)6.55
OCFY1.68%
SpS133.82
BVpS24.06
TBVpS16.76
PEG (NY)1.22
PEG (5Y)1.08
Graham Number66.91
Profitability
Industry RankSector Rank
ROA 10.85%
ROE 35.33%
ROCE 26.62%
ROIC 21.33%
ROICexc 23.67%
ROICexgc 30.35%
OM 7.33%
PM (TTM) 6.35%
GM 12.04%
FCFM 3.53%
ROA(3y)4.63%
ROA(5y)3.55%
ROE(3y)15.02%
ROE(5y)11.3%
ROIC(3y)11.43%
ROIC(5y)8.93%
ROICexc(3y)13.32%
ROICexc(5y)10.55%
ROICexgc(3y)18.44%
ROICexgc(5y)14.81%
ROCE(3y)14.26%
ROCE(5y)11.14%
ROICexgc growth 3Y31.4%
ROICexgc growth 5Y28.76%
ROICexc growth 3Y37.65%
ROICexc growth 5Y29.81%
OM growth 3Y24.27%
OM growth 5Y29.03%
PM growth 3Y34%
PM growth 5Y30.13%
GM growth 3Y8.03%
GM growth 5Y10.39%
F-Score7
Asset Turnover1.71
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 1.97
Debt/EBITDA 0.76
Cap/Depr 94.54%
Cap/Sales 1.37%
Interest Coverage 15.59
Cash Conversion 55.82%
Profit Quality 55.56%
Current Ratio 1.47
Quick Ratio 0.88
Altman-Z 6.76
F-Score7
WACC14.84%
ROIC/WACC1.44
Cap/Depr(3y)94.48%
Cap/Depr(5y)73.42%
Cap/Sales(3y)1.62%
Cap/Sales(5y)1.34%
Profit Quality(3y)94.3%
Profit Quality(5y)151.44%
High Growth Momentum
Growth
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
EPS Next Y38.59%
EPS Next 2Y37.93%
EPS Next 3Y33.06%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%43.57%
Revenue Next Year32.94%
Revenue Next 2Y32.93%
Revenue Next 3Y28.15%
Revenue Next 5YN/A
EBIT growth 1Y62.33%
EBIT growth 3Y48.65%
EBIT growth 5Y42.42%
EBIT Next Year67.79%
EBIT Next 3Y43.39%
EBIT Next 5Y38.43%
FCF growth 1Y48.75%
FCF growth 3Y20.17%
FCF growth 5Y2.76%
OCF growth 1Y40.82%
OCF growth 3Y27.84%
OCF growth 5Y6.55%

CELESTICA INC / CLS.CA FAQ

Can you provide the ChartMill fundamental rating for CELESTICA INC?

ChartMill assigns a fundamental rating of 6 / 10 to CLS.CA.


What is the valuation status of CELESTICA INC (CLS.CA) stock?

ChartMill assigns a valuation rating of 5 / 10 to CELESTICA INC (CLS.CA). This can be considered as Fairly Valued.


What is the profitability of CLS stock?

CELESTICA INC (CLS.CA) has a profitability rating of 7 / 10.


What is the valuation of CELESTICA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CELESTICA INC (CLS.CA) is 47.14 and the Price/Book (PB) ratio is 16.2.


How financially healthy is CELESTICA INC?

The financial health rating of CELESTICA INC (CLS.CA) is 6 / 10.